General
Preferred name
UMECLIDINIUM BROMIDE
Synonyms
GSK573719A ()
Incruse ellipta ()
Umeclidinium (bromide) ()
Umeclidinium brom ()
Anoro ellipta ()
GSK-573719A ()
P&D ID
PD052245
CAS
869113-09-7
Tags
available
drug
Drug indication
Chronic obstructive pulmonary disease
Drug Status
approved
Max Phase
Phase 4
First approval
2013
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
DrugMAP
DrugMAP Approved Drugs
LSP-MoA library (Laboratory of Systems Pharmacology)
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
11
Properties
(calculated by RDKit )
Molecular Weight
507.18
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
8
Ring Count
6
Aromatic Ring Count
3
cLogP
2.14
TPSA
29.46
Fraction CSP3
0.38
Chiral centers
0.0
Largest ring
6.0
QED
0.37
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
Neuroscience
GPCR/G protein
Neuronal Signaling
Target
M1 mAChR
M2 mAChR
M3 mAChR
M4 mAChR
M5 mAChR
mAChR
MOA
AChR
Source data
